Yeqing Su

Title: Yeqing Su: Innovator in Pharmaceutical Chemistry

Introduction

Yeqing Su is a notable inventor based in Halifax, Canada. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds for medical applications. His work focuses on addressing conditions associated with pyruvate kinase deficiency.

Latest Patents

Yeqing Su holds a patent for "Crystalline forms of N-(4-(4-(cyclopropymethyl)piperazine-1-carbonyl)phenyl)quinoline-8-sulfonamide." This patent includes amorphous and crystalline hemisulfate salt forms of the compound. Additionally, it encompasses pharmaceutical compositions that utilize these forms, along with methods for their manufacture and applications in treating pyruvate kinase-related conditions.

Career Highlights

Yeqing Su is currently employed at Agios Pharmaceuticals, Inc., where he continues to advance his research in pharmaceutical innovations. His expertise in the field has led to the development of critical therapeutic solutions.

Collaborations

Yeqing has collaborated with talented colleagues such as Jacob P Sizemore and Liting Guo, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Yeqing Su's work exemplifies the impact of innovative research in the pharmaceutical industry. His contributions are paving the way for new treatments that can significantly improve patient outcomes.